User Support Reference Group

Page tree

Versions Compared

Old Version 9

changes.mady.by.user Nicola Ingram

Saved on

compared with

New Version Current

changes.mady.by.user Nicola Ingram

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Meeting recording:


Zoom Details in Meeting Invite

https://snomed.zoom.us/j/89353278760
Password: 113582

Join from PC, Mac, Linux, iOS or Android 

Attendees

In person:

Monica HarryNicola IngramHanne Johansen  Ian Spiers

Krista Lilly Michael Jones Megan Berry Theresa Barry Olivier Bodenreider Rutt Lindström Justin Stout Johannes Tomter Midtgård Guillermo Reynoso Alejandro Lopez Osornio Stuart Abbott Rob Hausam Stan Huff 

Online Julie M. James

Emma Melhuish David Mitchell Marta Pavón Garrido Shane Byrnes Ines Otegui

Wednesday 25th October at 13:30-15:00 EDT Atlanta local time.

This is 17:30-19:00 UTC for those attending virtually. 

Discussion items

ItemTopic

Discussion Points

Speaker 

Notes from Call
1
Reminder to record call!Monica Harry

MEETING RECORDINGS are stored here: https://drive.google.com/drive/folders/1_tIy8TQapc6cqCwqpvNK6RwfBIhYqzD4


2

Welcome and introductions 

Monica Harry


3Current topic

Current topic in review Anti-diabetic drugs: pre-filled cartridges 





Decision

All agreed concentration strength - see presentation for discussion points covered during this interesting item.

Julie James

View file
namePens clicks and dials V2 Oct23.pptx
height250

4International units and SNOMED CT clinical drugs 

Feedback on international units discussion from Editorial Advisory Group



Decision

All agreed with use of 'units' instead of 'international units'

Monica Harry

Nicki  Ingram


View file
nameUpdate on Abbreviations in product descriptions.pptx
height250

5DCAP PROJECT DISCUSSION

*Anti-diabetic drugs - review underway. Email Hanne to share worksheet and take part.

*The next area of work is proposed to be anti-epileptic drugs.

*The future and expanding new international drugs content. DCAP?

  • How to generate more DCAP member country involvement in review of concepts?
    Proposals:
    1. No longer require Reviewers to provide evidence for Clinical Drug. Therefore no need to research to locate Summary of Product Characteristics (SPC, SmPC).
    2. Only requirement would be to say if countries have the Clinical Drug in their content. Therefore could be a speedy automated check for duplicates.
  • How to involve more member countries in participating in providing initial lists of drugs for DCAP review, with authoritative references, for import to International edition?

Discussion

Hanne Fjeldstad Johansen

Julie James


6AOB


All


7Upcoming Calls and Events

Next call: